Anne Wojcicki is the Co-Founder, CEO, and Board Member of 23andMe, a company focused on genetic testing and personalized health. With a background in healthcare investing, including biotechnology companies, she is also a General Partner at Covalence Life Sciences Partners. Ms. Wojcicki has a strong research background in oncology and hematology, having worked as a Research Associate at the National Institute of Health and other esteemed institutions.